Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Compare top high-yield ETFs by income potential and durability to select funds that optimize retirement cash flow and resilience.
27,330 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A profile of the country’s only full-time spelling bee coach, whose high hourly rate and prize-based bonuses are resh...
CoreWeave reported a $740 million quarterly loss as it stacked up a record backlog and a massive Meta deal, underscor...
Premu launches a new feature that lets anyone create World Cup markets with up to 2.5x leverage and collect trading f...
Tokenized equities reach $5.5B market value this week, driven by SpaceX IPO access and expanding exchange support. An...
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
Just getting started with crypto? Knowing the right starting stake matters. This guide breaks down the average invest...
Supermicro sits at the intersection of exploding AI demand and serious credibility concerns. This article breaks down...
Two former NBA players, Malik Beasley and Ed Davis, were named in a Brooklyn indictment tied to a large betting schem...
Hon Hai Precision posts a 40% quarterly jump, powered by AI server demand. The result highlights ongoing AI spending ...
Big events bring big costs beyond ticketing and catering. Explore what a six-figure NYC permit can teach about budget...
Rivian stock fell first half 2026 as a mix of delivery updates, new model momentum, and macro headwinds shaped invest...